Moving the Needle Through Innovation in ADC Chemistry, Improving Patient Stratification for Clinical Trials & Optimizing Manufacturing Efficiency to Progress ADCs to Standard of Care Oncology Treatments
As antibody-drug conjugates aspire to advance to earlier-line treatments, harnessing innovation has never been more important to redefine the oncology standard of care and provide long-term benefit to patients.
Returning as the annual touchpoint for the global community, the 16th World ADC San Diego is THE week to fully immerse yourself in all things antibody-drug conjugate, spotlighting the cutting-edge innovation empowering the industry to develop differentiated ADCs that show clear advantages against standard-of-care therapies with clinically meaningful patient benefit.
With 7 streams of end-to-end content spanning discovery chemistry, discovery biology, preclinical, translational medicine, clinical lessons, process and analytical development, and manufacturing and supply chain: this is your one-stop bioconjugate shop to bring your team up to speed with ADC fundamentals, get answers to the problems hindering your ADC R&D, and identify emerging trends to ensure you stay ahead of the curve.
Providing unparalleled networking opportunities with 1,400+ attendees from start-ups, biotechs, large pharma and leading service providers, anybody who is anybody in the ADC field will unite under one roof to innovate, collaborate, and redefine the standard of oncology care.Â
Cutting-Edge, End-to-End Scientific Content for All Stages of ADC Development
From new entrants to long-standing experts in the ADC field, 2025's 7-track program will delve into:







Snapshot of World Class ADC Speakers
Attending Companies Include


















About the World ADC Event Series
The World ADC team ploughs its collective energy into sourcing the insights you need. We investigate the most challenging problems facing the industry; source the leading experts who have game-changing solutions; and distil this into accessible formats of information exchange – for you. From globally leading conferences to webinars and industry reports, whatever the information you need, World ADC can offer you the insights you need to accelerate your ADC programs.
The value that World ADC provides you with is the power of insight and connections. Not artificial, and not short-lived. We nurture the right environments in which people can communicate problems and solutions; share novel data and forge networks across the industry that will make each of your endeavors more informed and more robust.
We share a common belief with the industry – that the potential of antibody-drug conjugates is enormous. In the war against cancer, ADCs are shaping up to advance towards earlier line treatments, shaping the oncology standard of care and providing long-term benefit to patients.
Join us at the heart of the ADC community to improve your programs and be part of the mission to develop better antibody drug conjugate drugs for patients faster.
